Showing results (421-430 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|July 1, 2018
Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in BrazilJuan Carlos Montano-Pedroso, Elvio Bueno Garcia, Mariana Alcântara Rodrigues de Moraes, et al.
The Lancet. Haematology|June 18, 2017
Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysisMary Eapen, Tao Wang, Paul A Veys, et al.
The Lancet. Haematology|October 4, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort studyClaudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, et al.
The Lancet. Haematology|October 4, 2016
Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case seriesJan Beyer-Westendorf, Franziska Michalski, Luise Tittl, et al.
The Lancet. Haematology|March 25, 2017
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trialRuben A Mesa, Alessandro M Vannucchi, Adam Mead, et al.
The Lancet. Haematology|January 15, 2016
Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysisShahrukh Hashmi, Mohammad Ahmed, M Hassan Murad, et al.
The Lancet. Haematology|December 22, 2015
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot studyScott F Huntington, Brendan M Weiss, Dan T Vogl, et al.
The Lancet. Haematology|December 22, 2015
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based studyColm Keane, Frank Vari, Mark Hertzberg, et al.
The Lancet. Haematology|December 22, 2015
Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5)Morgane Mounier, Nadine Bossard, Laurent Remontet, et al.
The Lancet. Haematology|December 22, 2015
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation studyPaul G Richardson, Sundar Jagannath, Philippe Moreau, et al.
Pageof 73